3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
7
Recruiting
2
Completed
2
Withdrawn
1
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
10
Esophageal Neoplasms
5
Colorectal Neoplasms
5
Rectal Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Carcinoma, Non-Small-Cell Lung
4
Adenocarcinoma Of Esophagus
4
Sarcoma
3
Lung Neoplasms
3
Uterine Cervical Neoplasms
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Neoplasms
2
Melanoma
2
Vomiting
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Peritoneal Metastases From Gastric Cancer
1
Peritoneal Metastases From Colorectal Cancer
1
Neurofibrosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms, Squamous Cell
1
Neoplasm Metastasis
1
Nausea
1
Multiple Myeloma
1
Malignant mesenchymal tumor
1
Interventions
Sorafenib
29
Nivolumab
15
pembrolizumab
12
Radiosurgery
9
Bevacizumab
9
atezolizumab
7
regorafenib
5
Radiotherapy
5
Fluorouracil
5
Doxorubicin
5
lenvatinib
4
Sunitinib
4
Oxaliplatin
4
Ipilimumab
4
Gemcitabine
4
Ethiodized Oil
4
Erlotinib Hydrochloride
4
Capecitabine
4
TLC 388
3
Radiofrequency Ablation
3
Leucovorin
3
Everolimus
3
Cisplatin
3
Blood Specimen Collection
3
toripalimab
2
phosphomannopentaose sulfate
2
durvalumab
2
cediranib
2
avelumab
2
Tirapazamine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Carcinoma, Hepatocellular
×
Neoadjuvant Therapy
×
Clear all
NCT05137899
2025-03-11
ADVANCE HCC
Ontario Clinical Oncology Group (OCOG)
Phase 2
Terminated
1 enrolled